Esomeprazole and omeprazole could enhance the serum concentrations of benzodiazepines (by means of CYP2C19 inhibition) bringing about increased adverse effects including drowsiness, although the clinical relevance is minimal in many clients – monitor the patient for adverse effects (e.If affected person simply cannot resume their common oral medi

Esomeprazole and omeprazole may well increase the serum concentrations of benzodiazepines (by using CYP2C19 inhibition) leading to improved adverse effects for example drowsiness, Even though the medical relevance is minimal in many individuals – keep track of the affected person for adverse effects (e.If client can't resume their standard oral m